Statins Shown to Extend Life by Mere Days

A 2018 review presents substantial evidence that total cholesterol and LDL cholesterol levels are not an indication of heart disease risk, and that statin treatment is of “doubtful benefit” as a form of primary

prevention for this reason.

Tactics used in statin studies to exaggerate benefits include excluding unsuccessful trials, cherry-picking data, ignoring the most important outcome — an increase in life expectancy — and using a statistical

tool called relative risk reduction to amplify trivial effects

If you look at absolute risk, statin drugs benefit just 1% of the treated participants. Out of 100 people treated with statins for five years, one person will have one less heart attack
Statin trials minimize health risks by using a run-in period. Participants are given the drug for a few weeks, after which those who suffer adverse effects are simply excluded, thereby lowering the perceived

frequency and severity of side effects

https://articles.mercola.com/sites/articles/archive/2019/09/11/do-statins-prolong-life.aspx?utm_source=dnl&utm_medium=email&utm_content=art1HL&utm_campaign=20190911Z1&et_cid=DM341182&et_rid=705731296